HER2 Expression Detection and Radionuclide Therapy in Breast Cancer Using 99mTc/188Re Labeled Single Domain Antibody
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Radiotoxicity
Interventions: DRUG: Injection of 99mTc-NM-02|DRUG: Injection of 188Re-NM-02
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Collaborators: NanoMab Technology (UK) Limited